Pancreas
Validation of two plasma multimetabolite signatures for patients at risk of or with suspected pancreatic ductal adenocarcinoma (METAPAC)
11/2025
Validation of two plasma multimetabolite signatures for patients at risk of or with suspected pancreatic ductal adenocarcinoma (METAPAC)
COX2 inhibitor therapy for acute pancreatitis
10/2025
COX2 inhibitor therapy for acute pancreatitis
Rectal diclofenac versus indomethacin for prevention of post-ERCP pancreatitis
08/2025
Rectal diclofenac versus indomethacin for prevention of post-ERCP pancreatitis
Risk factors for pancreatic cancer related to IPMN without high-risk stigm
06/2025
Risk factors for pancreatic cancer related to intraductal papillary mucinous neoplasms (IPMN) without high-risk stigm
Aspirin and pancreatic cancer risk in diabetes
05/2025
Aspirin and pancreatic cancer risk in diabetes
Adverse events associated with endoscopic retrograde cholangiopancreatography (ERCP)
04/2025
Adverse events associated with endoscopic retrograde cholangiopancreatography (ERCP)
Endoscopic sphincterotomy and risk of post-ERCP pancreatitis after insertion of self-expandable metal stents
03/2025
Endoscopic sphincterotomy and risk of post-ERCP pancreatitis after insertion of self-expandable metal stents
Endoscopic sphincterotomy for sphincter of Oddi dysfunction
02/2025
Endoscopic sphincterotomy for sphincter of Oddi dysfunction
Prognostic factors for early recurrence after resection of pancreatic cancer
01/2025
Prognostic factors for early recurrence after resection of pancreatic cancer:
Precision chemotherapy decisions based on organoids of advanced pancreatic cancer
12/2024
Precision chemotherapy decisions based on organoids of advanced pancreatic cancer
Impact of long-term transmural plastic stents on recurrence after endoscopic treatment of walled-off pancreatic necrosis - 9/2024
Impact of long-term transmural plastic stents on recurrence after endoscopic treatment of walled-off pancreatic necrosis
CEA as diagnostic marker for pancreatic mucinous cysts
7/2024
Cyst fluid carcinoembryonic antigen (CEA) as diagnostic marker for pancreatic mucinous cysts
Type 1 autoimmune pancreatitis in Europe: Clinical profile and response to treatment
6/2024
Type 1 autoimmune pancreatitis in Europe: Clinical profile and response to treatment
Long-term follow-up study of necrotising pancreatitis: Interventions, complications and quality of life
5/2024